We are live on ! Find out more
BG

BDF Gestion Portfolio holdings

AUM $747M
1-Year Est. Return 47.35%
This Fund
S&P 500
This Quarter Est. Return
+36.46%
1 Year Est. Return
+47.35%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$747M
AUM Growth
-$1.78M
Cap. Flow
-$85.9M
Cap. Flow %
-11.5%
Top 10 Hldgs %
46.56%
Holding
152
New
8
Increased
6
Reduced
120
Closed
9

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$8.41M
2
GE icon
GE Aerospace
GE
+$3.44M
3
TJX icon
TJX Companies
TJX
+$3.32M
4
MRVL icon
Marvell Technology
MRVL
+$2.95M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$1.76M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$19.7M
2
AAPL icon
Apple
AAPL
+$8.71M
3
MSFT icon
Microsoft
MSFT
+$7.81M
4
CRM icon
Salesforce
CRM
+$5.51M
5
KO icon
Coca-Cola
KO
+$5.49M

Sector Composition

Rank Sector Weight
1 Technology 26.02%
2 Industrials 22.31%
3 Financials 18.42%
4 Healthcare 12.32%
5 Consumer Discretionary 5.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REG icon
51
Regency Centers
REG
$13.8B
$3.56M 0.48%
15,588
-1,753
-10% -$138K
LH icon
52
Labcorp
LH
$26.5B
$3.46M 0.46%
6,869
-773
-10% -$203K
FTNT icon
53
Fortinet
FTNT
$115B
$3.43M 0.46%
28,855
-3,245
-10% -$375K
COR icon
54
Cencora
COR
$63.2B
$3.38M 0.45%
10,540
-1,186
-10% -$342K
ELV icon
55
Elevance Health
ELV
$88.4B
$3.32M 0.44%
4,181
-471
-10% -$175K
SYK icon
56
Stryker
SYK
$116B
$3.31M 0.44%
6,991
-787
-10% -$248K
MRK icon
57
Merck
MRK
$371B
$3.29M 0.44%
42,451
-4,773
-10% -$559K
ICE icon
58
Intercontinental Exchange
ICE
$90.5B
$3.12M 0.42%
11,587
-1,303
-10% -$196K
PGR icon
59
Progressive
PGR
$127B
$3.09M 0.41%
13,484
-1,516
-10% -$306K
MAR icon
60
Marriott International
MAR
$87.8B
$3.08M 0.41%
6,935
-780
-10% -$288K
MET icon
61
MetLife
MET
$62B
$3.06M 0.41%
36,562
-4,111
-10% -$332K
MSCI icon
62
MSCI
MSCI
$41.7B
$3.02M 0.4%
1,676
-189
-10% -$110K
NBIX icon
63
Neurocrine Biosciences
NBIX
$15.8B
$3M 0.4%
+11,858
New +$1.76M
AMAT icon
64
Applied Materials
AMAT
$361B
$2.99M 0.4%
19,099
-2,148
-10% -$991K
GILD icon
65
Gilead Sciences
GILD
$187B
$2.97M 0.4%
21,801
-2,452
-10% -$323K
VRSK icon
66
Verisk Analytics
VRSK
$24.2B
$2.88M 0.39%
6,042
-680
-10% -$120K
CSCO icon
67
Cisco
CSCO
$431B
$2.83M 0.38%
67,289
-7,565
-10% -$791K
REGN icon
68
Regeneron Pharmaceuticals
REGN
$85.2B
$2.8M 0.38%
1,524
-172
-10% -$117K
BSX icon
69
Boston Scientific
BSX
$69.3B
$2.8M 0.37%
51,301
-5,768
-10% -$313K
ORCL icon
70
Oracle
ORCL
$457B
$2.78M 0.37%
42,235
-4,749
-10% -$861K
SPGI icon
71
S&P Global
SPGI
$131B
$2.64M 0.35%
5,514
-621
-10% -$262K
VRTX icon
72
Vertex Pharmaceuticals
VRTX
$138B
$2.62M 0.35%
4,370
-492
-10% -$218K
GS icon
73
Goldman Sachs
GS
$302B
$2.62M 0.35%
6,320
-711
-10% -$693K
MA icon
74
Mastercard
MA
$507B
$2.61M 0.35%
12,956
-1,457
-10% -$726K
STX icon
75
Seagate
STX
$192B
$2.56M 0.34%
3,631
+1,500
+70% +$1.14M

Similar funds

BDF Gestion's Q2 2026 Portfolio in Review

As of Q2 2026, BDF Gestion held 152 positions worth $747M, down 0.24% from $749M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

BDF Gestion withdrew a net $85.9M in Q2 2026, closing 9 positions and reducing 120 holdings. Its most notable exit was Salesforce, an estimated $5.51M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 48% a quarter earlier, followed by Industrials and Financials.

Against the trend, BDF Gestion opened a new position in Intel worth $2.09M.

  • BDF Gestion's largest Q2 2026 buy was Intel: 83,126 shares worth $2.09M.
  • BDF Gestion added most to Micron Technology in Q2 2026, an estimated $1.65M increase.
  • BDF Gestion's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $19.7M.
  • BDF Gestion fully exited Salesforce in Q2 2026, selling an estimated $5.51M.
  • BDF Gestion's ten largest holdings make up 47% of its $747M portfolio in Q2 2026.
  • BDF Gestion opened 8 new positions and closed 9 in Q2 2026.
  • BDF Gestion's portfolio value fell 0.24% quarter-over-quarter to $747M.

Based on BDF Gestion's 13F filing for Q2 2026, filed 7 Jul 2026.